Clinical trial
Beraprost-314d Added-on to Tyvaso® (BEAT)
NCT01908699
Study timeline
Study start (actual)2013-05-31Date precision: day
Registry last updated2020-08-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
Sponsors & collaborators
Lung Biotechnology PBClead sponsor
Mapped research locations
New YorkNew York, United States3Los AngelesCalifornia, United States3ChicagoIllinois, United States2BaltimoreMaryland, United States2AtlantaGeorgia, United States2PittsburghPennsylvania, United States2JacksonvilleFlorida, United States2OrlandoFlorida, United States2LouisvilleKentucky, United States2HoustonTexas, United States1BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01908699 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.